Who makes BIBW 2948 BS for oral inhalation?

BIBW 2948 BS for oral inhalation is developed by Boehringer Ingelheim.

What development phase is BIBW 2948 BS for oral inhalation in?

BIBW 2948 BS for oral inhalation is in Phase 1.

Last reviewed 2026-04-20 · How we verify

BIBW 2948 BS for oral inhalation

Boehringer Ingelheim · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	BIBW 2948 BS for oral inhalation
Sponsor	Boehringer Ingelheim
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BIBW 2948 BS for oral inhalation CI brief — competitive landscape report
BIBW 2948 BS for oral inhalation updates RSS · CI watch RSS
Boehringer Ingelheim portfolio CI